Skip to main content
Top

Open Access 17-04-2025 | BRIEF REPORT

Physical activity, sedentary behaviour and health-related quality of life in 929 women with primary Raynaud’s phenomenon

Authors: Saskia Corine van de Zande, Karin Eijkelenkamp, Amaal Eman Abdulle, Andries Jan Smit, Johannes Zwerver, Inge van den Akker-Scheek, Douwe Johannes Mulder

Published in: Clinical Rheumatology

Login to get access

Abstract

Introduction

Women with primary Raynaud’s phenomenon (RP) often experience a decreased health-related quality of life (HRQoL). A physically active lifestyle could improve vascular function and HRQoL.

Objective

This study aimed to quantify the amount and type of physical activity (PA) and sedentary behaviour, as well as HRQoL and stress, in women with primary RP from a large population-based cohort (Lifelines).

Methods

A total of 19,820 adult (≥ 18 years) women from the Lifelines cohort were included; 929 of these were classified as having RP based on the connective tissue disease (CTD) screening questionnaire. Participant characteristics, data on PA and sedentary behaviour, HRQoL and stress were retrieved from the database.

Results

Women with RP reported 300 min/week minutes of moderate-to-vigorous physical activity (MVPA), which was more than women without RP (255 min/week, p ≤ .001). Women (74%) with RP complied to health enhancing PA guidelines (70% of women without RP, p = .003). Sedentary time was comparable. Women with RP had a low score on almost all eight domains of the HRQoL questionnaire. The Long-term Difficulties Inventory (LDI) showed a high stress level in the RP group (p < .001).

Conclusion

Most women with RP reported to spent a sufficient amount of time on MVPA and thus comply to health enhancing PA guidelines. The PA and sedentary behaviour of women with RP seems comparable to that of women without RP. However, HRQoL was lower and stress levels were higher in women with RP; more research is needed to elucidate the relation between PA and HRQoL in RP.
Key Points
Experiencing symptoms of Raynaud’s phenomenon seem no obstacle for being physically active.
Focus on women with symptoms of Raynaud’s phenomenon in a large cohort.
Nearly 75% of the women with symptoms of Raynaud’s phenomenon comply to the physical activity guidelines.
Women with symptoms of Raynaud’s phenomenon have low levels of health-related quality of life and experience a high stress level.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Physical activity, sedentary behaviour and health-related quality of life in 929 women with primary Raynaud’s phenomenon
Authors
Saskia Corine van de Zande
Karin Eijkelenkamp
Amaal Eman Abdulle
Andries Jan Smit
Johannes Zwerver
Inge van den Akker-Scheek
Douwe Johannes Mulder
Publication date
17-04-2025
Publisher
Springer International Publishing
Published in
Clinical Rheumatology
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-025-07416-w

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar